GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biocartis Group NV (XBRU:BCART) » Definitions » 12-1 Month Momentum %

Biocartis Group NV (XBRU:BCART) 12-1 Month Momentum % : -48.85% (As of May. 29, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Biocartis Group NV 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-29), Biocartis Group NV's 12-1 Month Momentum % is -48.85%.

The industry rank for Biocartis Group NV's 12-1 Month Momentum % or its related term are showing as below:

XBRU:BCART's 12-1 Month Momentum % is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: -20.39 vs XBRU:BCART: -48.85

Competitive Comparison of Biocartis Group NV's 12-1 Month Momentum %

For the Diagnostics & Research subindustry, Biocartis Group NV's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocartis Group NV's 12-1 Month Momentum % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biocartis Group NV's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Biocartis Group NV's 12-1 Month Momentum % falls into.



Biocartis Group NV  (XBRU:BCART) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biocartis Group NV  (XBRU:BCART) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Biocartis Group NV 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Biocartis Group NV's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocartis Group NV (XBRU:BCART) Business Description

Traded in Other Exchanges
N/A
Address
Generaal de Wittelaan 11 B, Mechelen, BEL, 2800
Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an MDx Idylla molecular diagnostic system for oncology and infectious disease segments. Its products include EGFR mutation assay, BRAF mutation test, NRAS mutation test, respiratory panel, etc. The firm derives the majority of its revenues from product sales.

Biocartis Group NV (XBRU:BCART) Headlines

No Headlines